Seller record · Telehealth service

CMWL

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The product pages refer only to a U.S. licensed compounding pharmacy, the answers to LegitScript-certified pharmacy partners, and the terms to a pharmacy licensed in the buyer's state. 1 more criterion also fails; see the table below.

At a glance

CMWLTelehealth service

5/8criteria passed

Price: Semaglutide $149 a month, or from $74 a month on the annual plan; tirzepatide $239, or from $119
Sells: compounded semaglutide, compounded tirzepatide, semaglutide microdose, and 1 more
FDA letters: None on file

Visit CMWL See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

The Center for Medical Weight Loss, a physician-led weight loss network that began as in-person clinics and now sells compounded semaglutide and tirzepatide online, with monthly, three-month and annual plans and a lower-dose maintenance program. No pharmacy is named.

Operating entity BE-THIN, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	CMWL's website; CMWL's products page; CMWL's about page
S2	Prescription gating	NOT VERIFIED	CMWL's products page; CMWL's website
S3	Pharmacy identification	FAIL	CMWL's products page; CMWL's website; CMWL's terms of use page
S4	Compounding disclosure	PASS	CMWL's website; CMWL's products page; CMWL's lowdose page
S5	Analytical documentation	FAIL	CMWL's products page; CMWL's medical safety information page; CMWL's terms of use page
S6	Business address	PASS	CMWL's terms of use page; CMWL's HIPAA privacy policy; CMWL's privacy policy
S7	Price disclosure	PASS	CMWL's products page; CMWL's lowdose page; CMWL's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe home page says every plan is reviewed and prescribed by a licensed, board-certified provider, the product pages say a board-certified physician in the buyer's state reviews the intake, and the about page names the chief medical officer.Source: CMWL's website; CMWL's products page; CMWL's about page.

S2NOT VERIFIEDThe order path behind the checkout buttons on the product pages did not resolve, because those buttons lead to a checkout that was not opened, while the same page says nothing is charged until a physician approves the buyer and the home page starts with a health history quiz. The check is open.Source: CMWL's products page; CMWL's website.

S3FAILNo filling pharmacy is named. The product pages refer only to a U.S. licensed compounding pharmacy, the answers to LegitScript-certified pharmacy partners, and the terms to a pharmacy licensed in the buyer's state.Source: CMWL's products page; CMWL's website; CMWL's terms of use page.

S4PASSThe home, product and microdosing pages state that compounded medications have not been evaluated or approved by the FDA, and the microdosing answers say plainly that compounded tirzepatide is not FDA-approved.Source: CMWL's website; CMWL's products page; CMWL's lowdose page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the answers, the medication safety information page or the terms.Source: CMWL's products page; CMWL's medical safety information page; CMWL's terms of use page.

S6PASSBE-THIN, Inc., doing business as The Center for Medical Weight Loss, at 50 N. Broadway, #280, Tarrytown, NY 10591, printed as the mailing address in the terms and in the HIPAA privacy notice. The terms name Delaware law.Source: CMWL's terms of use page; CMWL's HIPAA privacy policy; CMWL's privacy policy.

S7PASSCompounded semaglutide at $149 a month month to month, $298 every three months, which the page puts at $99 a month, or $894 a year at $74 a month. Compounded tirzepatide at $239 a month, $478 every three months at $159 a month, or $1,434 a year at $119 a month. Each price covers medication, clinical care and shipping. The maintenance microdose costs $83 a month for semaglutide and from $116 a month for tirzepatide, with a three-month minimum.Source: CMWL's products page; CMWL's lowdose page; CMWL's website.

S8PASSNo FDA warning letter names CMWL, The Center for Medical Weight Loss or BE-THIN, Inc., and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, semaglutide microdose, tirzepatide microdose.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit CMWL

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.